A severe case of IgA bullous pemphigoid successfully treated with dupilumab

Dermatol Ther. 2022 Nov;35(11):e15890. doi: 10.1111/dth.15890. Epub 2022 Oct 10.

Authors

Mario Valenti^{1

2}, Pierfrancesco De Giacomo³, Annamaria Lavecchia⁴, Giancarlo Valenti³

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
² Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
³ Dermatology Unit, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
⁴ S.O.C. Pathologic Anatomy, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.

PMID: 36181411
DOI: 10.1111/dth.15890

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Immunoglobulin A
Pemphigoid, Benign Mucous Membrane*
Pemphigoid, Bullous* / diagnosis
Pemphigoid, Bullous* / drug therapy

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Immunoglobulin A